Oct 15, 2021

Featuring perspectives from Drs Leonard Gomella, Maha Hussain, A Oliver Sartor and Neal Shore, including the following topics:

• Nonmetastatic (M0) Castration-Resistant Prostate Cancer (CRPC)
  • Introduction: Personalized Continuing Medical Education (0:00)
  • Case: A man in his early 70s with M0 CRPC — Gordon A Brown, DO (9:48)
  • Case: A man in his late 70s with M0 CRPC — Sulfi Ibrahim, MD (17:13)
  • Case: A man in his mid-70s with M0 CRPC — Jason Hafron, MD (22:11)
• Metastatic Hormone-Sensitive Prostate Cancer
  • Case: A man in his late 60s with metastatic hormone-sensitive prostate cancer — Dr Brown (38:40)
• PARP Inhibitors in the Management of Metastatic CRPC (mCRPC)
  • Case: A man in his mid-50s with mCRPC and a BRCA2 mutation — Dr Brown (48:53)
  • Case: A man in his mid-70s with mCRPC and a somatic BRCA2 homozygous deletion — Dr Hafron (1:13:08)
  • Case: A man in his mid-70s with mCRPC and a BRCA2 mutation — Dr Ibrahim (1:18:36)

CME information and select publications